Mainz Biomed in collaboration with Instituto de Microecologia
Vital link-up aims to expand ColoAlert detection tests in Europe and increase early cancer diagnosis
Read More
Tag: mainz biomed
Mainz Biomed explores markets in UK and Spain for ColoAlert
Market in Spain is around 26 million patients while the greater London area stands at nine million
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
